GJB2 gene therapy (Akouos/Eli Lilly)

N/A

Report date: 2025/01/26 15:41:26

Base Information

Drug NameGJB2 gene therapy (Akouos/Eli Lilly)
Drug Alias NameGJB2 gene therapy (Akouos)
ClassificationBiologics
Mechanisms of ActionGap junction beta-2 protein gene transference
TargetsGap junction beta-2 protein
Therapy Area/IndicationsHearing Loss
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAkouos Inc
China Registration ClassN/A

Develop Information

Active CompaniesAkouos Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A